482 related articles for article (PubMed ID: 15955221)
21. Analysis of MMP-1 and MMP-9 promoter polymorphisms in early osseointegrated implant failure.
Santos MC; Campos MI; Souza AP; Trevilatto PC; Line SR
Int J Oral Maxillofac Implants; 2004; 19(1):38-43. PubMed ID: 14982353
[TBL] [Abstract][Full Text] [Related]
22. Effect of MMP-1 promoter polymorphisms on GCF MMP-1 levels and outcome of periodontal therapy in patients with severe chronic periodontitis.
Pirhan D; Atilla G; Emingil G; Sorsa T; Tervahartiala T; Berdeli A
J Clin Periodontol; 2008 Oct; 35(10):862-70. PubMed ID: 18710412
[TBL] [Abstract][Full Text] [Related]
23. The promoter polymorphism of the matrix metalloproteinase 3 (MMP-3) gene in women with ovarian cancer.
Szyllo K; Smolarz B; Romanowicz-Makowska H; Niewiadomski M; Kozlowska E; Kulig A
J Exp Clin Cancer Res; 2002 Sep; 21(3):357-61. PubMed ID: 12385578
[TBL] [Abstract][Full Text] [Related]
24. Association between chronic hepatitis B virus infection and interleukin-10, tumor necrosis factor-alpha gene promoter polymorphisms.
Cheong JY; Cho SW; Hwang IL; Yoon SK; Lee JH; Park CS; Lee JE; Hahm KB; Kim JH
J Gastroenterol Hepatol; 2006 Jul; 21(7):1163-9. PubMed ID: 16824070
[TBL] [Abstract][Full Text] [Related]
25. [Association of functional polymorphisms in matrix metalloproteinase-2 (MMP-2) and MMP-9 genes with risk of gastric cancer in a Chinese population].
Zhang XM; Miao XP; Xiong P; Yu CY; Tan W; Qu SN; Sun T; Zhou YF; Lin DX
Ai Zheng; 2004 Nov; 23(11):1233-7. PubMed ID: 15522165
[TBL] [Abstract][Full Text] [Related]
26. Genetic association between matrix metalloproteinase MMP-9 and MMP-3 polymorphisms and Japanese sporadic Alzheimer's disease.
Shibata N; Ohnuma T; Higashi S; Usui C; Ohkubo T; Kitajima A; Ueki A; Nagao M; Arai H
Neurobiol Aging; 2005 Jul; 26(7):1011-4. PubMed ID: 15748780
[TBL] [Abstract][Full Text] [Related]
27. Genetic polymorphisms of the matrix metalloproteinase-3 (MMP-3) and tissue inhibitors of matrix metalloproteinases-1 (TIMP-1) modulate the development of ankylosing spondylitis.
Wei JC; Lee HS; Chen WC; Shiu LJ; Yang SF; Wong RH
Ann Rheum Dis; 2009 Nov; 68(11):1781-6. PubMed ID: 19019896
[TBL] [Abstract][Full Text] [Related]
28. Functional -1562 C-to-T polymorphism in matrix metalloproteinase-9 (MMP-9) promoter is associated with the risk for oral squamous cell carcinoma in younger male areca users.
Tu HF; Wu CH; Kao SY; Liu CJ; Liu TY; Lui MT
J Oral Pathol Med; 2007 Aug; 36(7):409-14. PubMed ID: 17617834
[TBL] [Abstract][Full Text] [Related]
29. Association of interferon regulatory factor-7 gene polymorphism with liver cirrhosis in chronic hepatitis C patients.
Sermasathanasawadi R; Kato N; Muroyama R; Dharel N; Shao RX; Chang JH; Li CZ; Kawabe T; Omata M
Liver Int; 2008 Jul; 28(6):798-806. PubMed ID: 18397234
[TBL] [Abstract][Full Text] [Related]
30. PCR analysis of matrix metalloproteinase 3 (MMP-3) gene promoter polymorphism in ovarian cancer.
Smolarz B; Szyłło K; Romanowicz-Makowska H; Niewiadomski M; Kozłowska E; Kulig A
Pol J Pathol; 2003; 54(4):233-8. PubMed ID: 14998290
[TBL] [Abstract][Full Text] [Related]
31. Association of matrix metalloproteinase (MMP-1, MMP-3 and MMP-9) and cyclooxygenase-2 gene polymorphisms and their proteins with chronic periodontitis.
Loo WT; Wang M; Jin LJ; Cheung MN; Li GR
Arch Oral Biol; 2011 Oct; 56(10):1081-90. PubMed ID: 21481333
[TBL] [Abstract][Full Text] [Related]
32. A single nucleotide polymorphism in the matrix metalloproteinase-3 promoter enhances breast cancer susceptibility.
Ghilardi G; Biondi ML; Caputo M; Leviti S; DeMonti M; Guagnellini E; Scorza R
Clin Cancer Res; 2002 Dec; 8(12):3820-3. PubMed ID: 12473595
[TBL] [Abstract][Full Text] [Related]
33. Body composition and muscular strength changes after moderate activity: association with matrix metalloproteinase polymorphisms.
Fiotti N; Deiuri E; Altamura N; De Colle P; Moretti ME; Toigo G; Giansante C
Arch Gerontol Geriatr; 2009; 49 Suppl 1():83-94. PubMed ID: 19836620
[TBL] [Abstract][Full Text] [Related]
34. An association between the matrix metalloproteinase 1 promoter gene polymorphism and lymphnode metastasis in breast cancer.
Przybylowska K; Zielinska J; Zadrozny M; Krawczyk T; Kulig A; Wozniak P; Rykala J; Kolacinska A; Morawiec Z; Drzewoski J; Blasiak J
J Exp Clin Cancer Res; 2004 Mar; 23(1):121-5. PubMed ID: 15149160
[TBL] [Abstract][Full Text] [Related]
35. Association of matrix metalloproteinase-1 and -3 promoter polymorphisms with clinical subsets of Norwegian primary sclerosing cholangitis patients.
Wiencke K; Louka AS; Spurkland A; Vatn M; Schrumpf E; Boberg KM;
J Hepatol; 2004 Aug; 41(2):209-14. PubMed ID: 15288468
[TBL] [Abstract][Full Text] [Related]
36. Combined impact of matrix metalloproteinase-3 and paraoxonase 1 55/192 gene variants on coronary artery disease in Turkish patients.
Ozkök E; Aydin M; Babalik E; Ozbek Z; Ince N; Kara I
Med Sci Monit; 2008 Oct; 14(10):CR536-42. PubMed ID: 18830194
[TBL] [Abstract][Full Text] [Related]
37. Differential expression of matrix metalloproteinases in viral and non-viral chronic liver diseases.
Ljumovic D; Diamantis I; Alegakis AK; Kouroumalis EA
Clin Chim Acta; 2004 Nov; 349(1-2):203-11. PubMed ID: 15469875
[TBL] [Abstract][Full Text] [Related]
38. Functional polymorphisms in matrix metalloproteinase-1 and monocyte chemoattractant protein-1 and rheumatoid arthritis.
Lee YH; Kim HJ; Rho YH; Choi SJ; Ji JD; Song GG
Scand J Rheumatol; 2003; 32(4):235-9. PubMed ID: 14626631
[TBL] [Abstract][Full Text] [Related]
39. [Analysis of the gene polymorphism of matrix metalloproteinase-2 and -9 in patients with coronary heart disease].
Shevchenko AV; Golovanova OV; Konenkov VI; Tolkacheva OM; Maksimov VN; Voevoda MI; Romashchenko AG
Ter Arkh; 2010; 82(1):31-4. PubMed ID: 20364697
[TBL] [Abstract][Full Text] [Related]
40. Influence of genetic polymorphism in matrix metalloproteinase-3 on extent of coronary atherosclerosis and risk of coronary artery stenosis.
Seifi M; Fallah S; Firoozrai M
Arch Med Res; 2009 Oct; 40(7):600-4. PubMed ID: 20082876
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
